Showing results (681-690 of 1,983) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|October 16, 2022
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trialRiccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose, et al.
The Lancet. Neurology|July 21, 2012
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatmentPer Svenningsson, Eric Westman, Clive Ballard, et al.
The Lancet. Neurology|July 21, 2012
Advances and challenges in neurostimulation for headachesDelphine Magis, Jean Schoenen
The Lancet. Neurology|July 21, 2012
Disorders of consciousness: responding to requests for novel diagnostic and therapeutic interventionsRalf J Jox, James L Bernat, Steven Laureys, et al.
The Lancet. Neurology|September 22, 2012
The myotonic dystrophies: molecular, clinical, and therapeutic challengesBjarne Udd, Ralf Krahe
The Lancet. Neurology|September 22, 2012
Reversible cerebral vasoconstriction syndromeAnne Ducros
The Lancet. Neurology|August 2, 2012
Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification studyHendrik Rosewich, Holger Thiele, Andreas Ohlenbusch, et al.
The Lancet. Neurology|July 31, 2012
Timing of antiepileptic drug withdrawal and long-term seizure outcome after paediatric epilepsy surgery (TimeToStop): a retrospective observational studyKim Boshuisen, Alexis Arzimanoglou, J Helen Cross, et al.
The Lancet. Neurology|July 10, 2012
Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional studyCaroline K Mbuba, Anthony K Ngugi, Greg Fegan, et al.
The Lancet. Neurology|March 20, 2010
Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disordersMassimo Mantegazza, Giulia Curia, Giuseppe Biagini, et al.
Pageof 199